HTL Biotechnology
CEP Certificates (EDQM COS List)

HTL Biotechnology

CEP Database

Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.

Chemical France
  • Total Records 4
  • Latest End Date 2025-07-08
  • Data Source EDQM
  • Last Updated 2024-07-25
All
4
View
Valid
3
View
Withdrawn
1
View
Company Overview

Company

HTL Biotechnology

Country

France

Social Profiles

LinkedIn
Company Snapshot

HTL Biotechnology

7 Rue Alfred Kastler - ZI de l’Aumaillerie 35133 Javene

France

htlbiotech.com/ contact@htlbiotech.com View on Map
CEP Records Timeline (4 records)
2024
25 Jul
Chemical Valid

Product

Sodium hyaluronate, Alternative process; Intrinsic viscosity : less than 1.8 m3/kg, by fermentation, for parenteral and ophthalmic administration including intra-articular use and intra-ocular use

Substance

HTL Javené FR

Certificate No.

CEP 2012-335 - Rev 03

Substance No.

1472

Issue Date

2024-07-25

End Date

-

Country

France

Identifiers

Certificate No.: CEP 2012-335 - Rev 03
Substance No.: 1472

2024
24 Jul
Chemical Valid

Product

Sodium hyaluronate, Intrinsic viscosity: 1.7 m3/kg, 1.9 m3/kg, 2.4 m3/kg, 2.8 m3/kg, or 3.5 m3/kg, by fermentation, for parenteral administration including intra-articular use and intra-ocular use

Substance

HTL Javené FR

Certificate No.

CEP 2001-385 - Rev 09

Substance No.

1472

Issue Date

2024-07-24

End Date

-

Country

France

Identifiers

Certificate No.: CEP 2001-385 - Rev 09
Substance No.: 1472

2024
19 Jul
Chemical Valid

Product

Sodium hyaluronate, Intrinsic viscosity 0.2 to 2.4 m3/kg; by fermentation; for parenteral administration and for intra-ocular and intra-articular use

Substance

HTL Javené FR

Certificate No.

CEP 2004-238 - Rev 06

Substance No.

1472

Issue Date

2024-07-19

End Date

-

Country

France

Identifiers

Certificate No.: CEP 2004-238 - Rev 06
Substance No.: 1472

2019
03 Jul
Chemical Withdrawn by Holder

Product

Sodium hyaluronate, Alternative process, not less than 1.6m3/kg, by fermentation, for parenteral administration including intra-articular administration, and for intra-ocular use.

Substance

HTL S.A.S. Javené FR

Certificate No.

R1-CEP 2010-266 - Rev 02

Substance No.

1472

Issue Date

2019-07-03

End Date

2025-07-08

Country

France

Identifiers

Certificate No.: R1-CEP 2010-266 - Rev 02
Substance No.: 1472

Related Databases
  • FDA Inspections
    7 View
  • EDQM CEP
    4 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
Status Breakdown
4 total
  • Valid
  • Withdrawn by holder
Official Source

All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).

Visit EDQM
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Country

France

Identifiers

Certificate No.: CEP 2012-335 - Rev 03
Substance No.: 1472

100% Official Data

Directly from the EDQM CEP database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

CEP data is obtained from the official EDQM (European Directorate for the Quality of Medicines) database.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.